Substandard and falsified medical product recalls in Zambia from 2018 to 2021 and implications on the quality surveillance systems.

Chabalenge, Billy; Jere, Elimas; Nanyangwe, Namuchindo; Hikaambo, Christabel; Mudenda, Steward; Banda, Michelo; Kalungia, Aubrey; Matafwali, Scott

Chabalenge, Billy; Jere, Elimas; Nanyangwe, Namuchindo; Hikaambo, Christabel; Mudenda, Steward; Banda, Michelo; Kalungia, Aubrey; Matafwali, Scott.

Afiliação

Chabalenge B; Department of Medicines Control, Zambia Medicines Regulatory Authority, Lusaka, Zambia.
Jere E; Department of Medicines Control, Zambia Medicines Regulatory Authority, Lusaka, Zambia.
Nanyangwe N; Department of Medicines Control, Zambia Medicines Regulatory Authority, Lusaka, Zambia.
Hikaambo C; Department of Chemistry, Faculty of Science, University of Cape Town, Cape Town, South Africa.
Mudenda S; Department of Pharmacy, University of Zambia, Lusaka, Zambia.
Banda M; Department of Pharmacy, University of Zambia, Lusaka, Zambia.
Kalungia A; Department of Pharmacy, University of Zambia, Lusaka, Zambia.
Matafwali S; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.

J Med Access ; 6: 27550834221141767, 2022.

Article em En | MEDLINE | ID: mdl-36601496

Palavras-chave

Pharmacovigilance; ZAMRA; Zambia; falsified; medical products; recall; substandard

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Risk_factors_studies / Screening_studies Idioma: En Revista: J Med Access Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google